These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 16797179)

  • 41. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Raloxifene preserves bone strength and bone mass in ovariectomized rats.
    Turner CH; Sato M; Bryant HU
    Endocrinology; 1994 Nov; 135(5):2001-5. PubMed ID: 7956922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.
    Siddiqui JA; Swarnkar G; Sharan K; Chakravarti B; Sharma G; Rawat P; Kumar M; Khan FM; Pierroz D; Maurya R; Chattopadhyay N
    Mol Cell Endocrinol; 2010 Jul; 323(2):256-67. PubMed ID: 20380869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
    Mendoza S; Noa M; Mas R; Mendoza N
    Drugs Exp Clin Res; 2005; 31(5-6):181-91. PubMed ID: 16425974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss.
    Kimble RB; Kitazawa R; Vannice JL; Pacifici R
    Calcif Tissue Int; 1994 Oct; 55(4):260-5. PubMed ID: 7820776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
    Chen F; Ouyang Y; Ye T; Ni B; Chen A
    J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
    Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-regulation of osteoclast differentiation by daidzein via caspase 3.
    Rassi CM; Lieberherr M; Chaumaz G; Pointillart A; Cournot G
    J Bone Miner Res; 2002 Apr; 17(4):630-8. PubMed ID: 11918220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
    Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
    J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss.
    Kim TH; Jung JW; Ha BG; Hong JM; Park EK; Kim HJ; Kim SY
    J Nutr Biochem; 2011 Jan; 22(1):8-15. PubMed ID: 20233653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
    Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
    Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective estrogen receptor modulator ormeloxifene suppresses embryo implantation via inducing miR-140 and targeting insulin-like growth factor 1 receptor in rat uterus.
    Sirohi VK; Gupta K; Kumar R; Shukla V; Dwivedi A
    J Steroid Biochem Mol Biol; 2018 Apr; 178():272-282. PubMed ID: 29330027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.